TECON BIOLOGY Co.LTD (SHE:002100)

Market Cap	10.55B +14.0%
Revenue (ttm)	16.72B -4.9%
Net Income	-100.79M
EPS	-0.07
Shares Out	1.37B
PE Ratio	n/a
Forward PE	20.34
Dividend	0.22 (2.85%)
Ex-Dividend Date	n/a

Volume	37,091,231
Average Volume	36,995,628
Open	8.00
Previous Close	8.01
Day's Range	7.66 - 8.10
52-Week Range	6.08 - 8.46
Beta	0.68
RSI	49.45
Earnings Date	Apr 29, 2026

About TECON BIOLOGY Co.LTD

TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives. The Pharmaceutical division researches and develops livestock and poultry disease vaccine products; and cottonseed meal and oils, cotton hull, and short plush, as well as engages in pig genetics and breeding; commerci...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 5,004
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002100

Financial Performance

In 2025, TECON BIOLOGY Co.LTD's revenue was 16.98 billion, a decrease of -1.13% compared to the previous year's 17.18 billion. Earnings were 210.63 million, a decrease of -65.19%.